Qube Research & Technologies (QRT)
RGNX icon

Qube Research & Technologies (QRT)’s Regenxbio RGNX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,310,493
Closed -$11M – 3967
2026
Q1 		$11M Buy
1,310,493
+867,803
+196% +$9.12M 0.01% 1223
2025
Q4 		$6.37M Buy
442,690
+157,859
+55% +$1.97M 0.01% 1630
2025
Q3 		$2.75M Sell
284,831
-172,281
-38% -$1.52M ﹤0.01% 2079
2025
Q2 		$3.75M Buy
457,112
+64,317
+16% +$538K ﹤0.01% 1876
2025
Q1 		$2.81M Buy
392,795
+38,802
+11% +$289K ﹤0.01% 1821
2024
Q4 		$2.74M Buy
353,993
+159,919
+82% +$1.5M ﹤0.01% 1755
2024
Q3 		$2.04M Buy
194,074
+84,092
+76% +$1.03M ﹤0.01% 1756
2024
Q2 		$1.29M Buy
109,982
+67,010
+156% +$1.04M ﹤0.01% 1793
2024
Q1 		$905K Buy
42,972
+24,034
+127% +$428K ﹤0.01% 2201
2023
Q4 		$340K Buy
+18,938
New +$334K ﹤0.01% 2520
2023
Q2 		– Sell
-43,491
Closed -$822K – 2908
2023
Q1 		$822K Buy
43,491
+6,436
+17% +$142K ﹤0.01% 1368
2022
Q4 		$840K Buy
+37,055
New +$838K ﹤0.01% 1294
2021
Q2 		– Sell
-15,045
Closed -$513K – 2720
2021
Q1 		$513K Buy
+15,045
New +$642K 0.01% 1163

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Qube Research & Technologies (QRT)'s RGNX Position: Q2 2026 in Review

Qube Research & Technologies (QRT) sold out of Regenxbio (RGNX) in Q2 2026, closing a stake of 1,310,493 shares — an estimated $11M sold.

Qube Research & Technologies (QRT) first reported a position in RGNX in Q1 2021 and held it in 13 quarters. The position peaked at $11M in Q1 2026. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.

  • Qube Research & Technologies (QRT) reported no remaining Regenxbio position as of Q2 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 1,310,493 Regenxbio shares in Q2 2026, an estimated $11M.
  • Qube Research & Technologies (QRT) first reported a position in Regenxbio in Q1 2021 and held it in 13 quarters.
  • Qube Research & Technologies (QRT)'s Regenxbio position peaked at $11M in Q1 2026.
  • 165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.